TDP ‐43 proteinopathies and neurodegeneration: insights from Caenorhabditis elegans models
The FEBS Journal · 2026-01 · 293 (2) · 348-384
DOI: 10.1111/febs.70239 ↗At a glance
Übersichtsarbeit in The FEBS Journal, published online on 2025-09-02. Written by Ghulam Jeelani Pir and 7 co-authors. Institution: The Neuroscience Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar. Major MEDLINE topics: Caenorhabditis elegans, TDP-43 Proteinopathies, DNA-Binding Proteins, Caenorhabditis elegans Proteins. Cited 6 times so far (Crossref); 322 references. The full text is freely available in PubMed Central. Funded by: Katharina Hardt Foundation, NIH HHS, NIA NIH HHS.
Abstract (original language)
TDP‐linked proteinopathies, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and limbic‐predominant age‐related TDP‐43 encephalopathy (LATE), are characterised by pathogenic deposits containing transactive response DNA‐binding protein 43 (TDP‐43) in the brain and spinal cord of patients. These hallmark pathological features are associated with widespread neuronal dysfunction and progressive neurodegeneration. TDP‐43's role as an essential RNA/DNA‐binding protein in RNA metabolism and gene expression regulation is clear, but deciphering the intricate pathophysiological mechanisms underpinning TDP‐43‐mediated neurodegeneration is paramount for developing effective therapies and novel diagnostic tools for early detection before frank neuronal loss occurs. The nematode Caenorhabditis elegans , with highly conserved TDP‐43 orthologue TDP‐1, serves as a powerful genetic model to investigate the molecular underpinnings of TDP‐43 proteinopathies. Here, we provide a brief overview of the structural and functional characteristics of TDP‐43 and TDP‐1, highlighting their conserved roles in RNA metabolism, stress responses, and neurodegeneration. We then delve into the pathobiology of TDP‐43, drawing insights from C. elegans models expressing either monogenic TDP‐43 variants or bigenic combinations with ALS‐associated risk genes, and discuss how these models have advanced our understanding of the pathomechanisms of TDP‐43 proteinopathies. By employing its simplicity and genetic manipulability, we discuss how these models have helped identify chemical and genetic suppressors of TDP‐43‐induced phenotypes, including small molecules like Pimozide and the probiotic Lacticaseibacillus rhamnosus HA‐114, now in clinical trials. This review underscores the translational value of C. elegans in unraveling the biochemical pathways and interactions in TDP‐43 proteinopathies that perturb cellular physiology, potentially facilitating mechanism‐based therapy development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- The Neuroscience Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
- Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
- Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
- Department of Dermatology and Venereology, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
- Geriatrics Research Education and Clinical Center (GRECC), Veterans Affairs Puget Sound Healthcare System, Seattle, WA, USA.
- Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington Harborview Medical Center, Seattle, WA, USA.
ORCID profiles: Ghulam Jeelani Pir, Randall J Eck, Brian C Kraemer, Eckhard Mandelkow, Martin Steinhoff
Funding
- Katharina Hardt Foundation
- NIH HHS
- NIA NIH HHS
- Cure Alzheimer's Fund
- Qatar National Research Fund
- National Institutes of Health
Cite
APA
Pir, G. J., Buddenkotte, J., Alam, M. A., Own, A., Eck, R. J., Kraemer, B. C., Mandelkow, E., & Steinhoff, M. (2026). TDP ‐43 proteinopathies and neurodegeneration: insights from Caenorhabditis elegans models. The FEBS Journal, 293(2), 348-384. https://doi.org/10.1111/febs.70239
Vancouver
Pir GJ, Buddenkotte J, Alam MA, Own A, Eck RJ, Kraemer BC, et al. TDP ‐43 proteinopathies and neurodegeneration: insights from Caenorhabditis elegans models. The FEBS Journal. 2026;293(2):348-384. doi:10.1111/febs.70239
BibTeX
@article{Pir2026,
author = {Pir, Ghulam Jeelani and Buddenkotte, Joerg and Alam, Majid Ali and Own, Ahmed and Eck, Randall J and Kraemer, Brian C and Mandelkow, Eckhard and Steinhoff, Martin},
title = {TDP ‐43 proteinopathies and neurodegeneration: insights from Caenorhabditis elegans models},
journal = {The FEBS Journal},
year = {2026},
volume = {293},
number = {2},
pages = {348--384},
doi = {10.1111/febs.70239}
}
EUVIMED